Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5327)
All Articles published online
|
Publishing Process of This Article
|
May 24, 2021 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ippolito D, Maino C, Ragusi M, Porta M, Gandola D, Franzesi CT, Giandola TP, Sironi S. Immune response evaluation criteria in solid tumors for assessment of atypical responses after immunotherapy. World J Clin Oncol 2021; 12(5): 323-334 [PMID: 34131564 DOI: 10.5306/wjco.v12.i5.323] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i5/323.htm |
| Number | Citing Articles |
| 1 |
Yu Jiang, Baozhi Song, Zhiqin Chen, Min Tang. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/5936773
|
| 2 |
Davide Ippolito, Cesare Maino, Marco Gatti, Paolo Marra, Riccardo Faletti, Francesco Cortese, Riccardo Inchingolo, Sandro Sironi. Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy. World Journal of Gastroenterology 2023; 29(11): 1669-1684 doi: 10.3748/wjg.v29.i11.1669
|
| 3 |
Lanying Zhang, Tiantian Tian, Yingying Zhang, Shuliang Yu, Fangjie Chen, Lili Qiao, Pingping Hu, Jiandong Zhang. Pseudoprogression during immunotherapy for gastric adenocarcinoma: A case report and literature review. Journal of Cancer Research and Therapeutics 2023; 19(1): 144 doi: 10.4103/jcrt.jcrt_1050_22
|
| 4 |
Walid Shalata, Alexander Yakobson, Yulia Dudnik, Forat Swaid, Mohammad Sheikh Ahmad, Ashraf Abu Jama, Ahron Yehonatan Cohen, Abed Agbarya. Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer. Biomedicines 2023; 11(9): 2438 doi: 10.3390/biomedicines11092438
|
| 5 |
Rukmini Kumar, Timothy Qi, Yanguang Cao, Brian Topp. Incorporating lesion-to-lesion heterogeneity into early oncology decision making. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1173546
|
| 6 |
Ariel Hirschfeld, Daniel Gurell, Michael Har-Noy. Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy. Translational Medicine Communications 2024; 9(1) doi: 10.1186/s41231-024-00174-y
|
| 7 |
Yaping Guan, Dongfeng Feng, Beibei Yin, Kun Li, Jun Wang. Immune-related dissociated response as a specific atypical response pattern in solid tumors with immune checkpoint blockade. Therapeutic Advances in Medical Oncology 2022; 14 doi: 10.1177/17588359221096877
|
| 8 |
Luo Cheng, Heng Xiao. Sintilimab plus IBI305 for hepatocellular carcinoma. The Lancet Oncology 2021; 22(9): e387 doi: 10.1016/S1470-2045(21)00424-1
|
| 9 |
Naoshi Odagiri, Akihiro Tamori, Kohei Kotani, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, Sawako Uchida‑Kobayashi, Masaru Enomoto, Norifumi Kawada. A case of hepatocellular carcinoma with “pseudoprogression” followed by complete response to atezolizumab plus bevacizumab. Clinical Journal of Gastroenterology 2023; 16(3): 392 doi: 10.1007/s12328-023-01761-6
|
| 10 |
Shin Otake, Yu Ota, Kazunobu Aso, Mitsuyoshi Okada, Hidemi Hayashi, Takumu Hasebe, Shunsuke Nakajima, Koji Sawada, Mikihiro Fujiya, Toshikatsu Okumura. Contrast-enhanced Ultrasonography Features for Diagnosing Pseudoprogression of Hepatocellular Carcinoma with Immunotherapy: A Case Report of the Response after Pseudoprogression. Internal Medicine 2024; 63(8): 1093 doi: 10.2169/internalmedicine.2349-23
|